PHASE III TRIAL OF BEVACIZUMAB ADDED TO STANDARD RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY-DIAGNOSED GLIOBLASTOMA: MATURE PROGRESSION-FREE SURVIVAL AND PRELIMINARY OVERALL SURVIVAL RESULTS IN AVAGLIO

被引：0
|
作者：
Chinot, Olivier [1 ]
Wick, Wolfgang [2 ]
Mason, Warren [3 ]
Henriksson, Roger [4 ]
Saran, Frank [5 ]
Nishikawa, Ryo [6 ]
Hilton, Magalie [7 ]
Abrey, Lauren [7 ]
Cloughesy, Timothy [8 ]
机构：
[1] Aix Marseille Univ, AP HM, Marseille, France
[2] Univ Heidelberg Hosp, Heidelberg, Germany
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Royal Marsden NHS Fdn Trust, Surrey, England
[6] Saitama Med Univ, Saitama, Japan
[7] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[8] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
NEURO-ONCOLOGY | 2012年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [1] Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio
    Cloughsey, Timothy
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Hilton, Magalie
    Abrey, Lauren
    Chinot, Olivier
    [J]. NEUROLOGY, 2013, 80
  • [2] Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio
    Cloughsey, Timothy
    Wick, Wolfgang
    Mason, Warren
    Henriksson, Roger
    Saran, Frank
    Nishikawa, Ryo
    Hilton, Magalie
    Abrey, Lauren
    Chinot, Olivier
    [J]. NEUROLOGY, 2013, 80
  • [3] AVAglio: A phase III trial of bevacizumab added to standard radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.
    Chinot, O. L.
    Wick, W.
    Saran, F.
    Mason, W. P.
    Henriksson, R.
    Nishikawa, R.
    Zeaiter, A. H.
    Moore, N.
    Das, A.
    Cloughesy, T. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma
    Hemi Malkki
    [J]. Nature Reviews Neurology, 2014, 10 (4) : 179 - 179
  • [5] Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity
    Gruber, M. L.
    Raza, S.
    Gruber, D.
    Narayana, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Progression-free survival (PFS) and health-related quality of life (HRQoL) in AVAglio, a phase III study of bevacizumab (Bv), temozolomide (T), and radiotherapy (RT) in newly diagnosed glioblastoma (GBM)
    Henriksson, Roger
    Bottomley, Andrew
    Mason, Warren
    Saran, Frank
    Wick, Wolfgang
    Nishikawa, Ryo
    Cloughesy, Timothy Francis
    Carpentier, Antoine F.
    Khe Hoang-Xuan
    Kavan, Petr
    Cernea, Dana
    Brandes, Alba Ariela
    Hilton, Magalie
    Guijarro, Ana Maria Abajo
    Ravelo, Arliene
    Chinot, Oliver L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
    Chinot, O. L.
    Rouge, T. de la Motte
    Moore, N.
    Zeaiter, A.
    Das, A.
    Phillips, H.
    Modrusan, Z.
    Cloughesy, T.
    [J]. ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
  • [8] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
    O. L. Chinot
    T. de La Motte Rouge
    N. Moore
    A. Zeaiter
    A. Das
    H. Phillips
    Z. Modrusan
    T. Cloughesy
    [J]. Advances in Therapy, 2011, 28 : 334 - 340
  • [9] Correlation of molecular subtypes with survival in AVAglio (bevacizumab [Bv] and radiotherapy [RT] and temozolomide [T] for newly diagnosed glioblastoma [GB])
    Phillips, Heidi
    Sandmann, Thomas
    Li, Congfen
    Cloughesy, Timothy Francis
    Chlnot, Olivier L.
    Wick, Wolfgang
    Nishikawa, Ryo
    Mason, Warren P.
    Henriksson, Roger
    Saran, Frank
    Lai, Albert
    Moore, Nicola
    Hegde, Priti S.
    Abrey, Lauren E.
    Bourgon, Richard
    Garcia, Josep
    Bais, Carlos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] SAFETY RESULTS FROM AVAglio, A PHASE III RANDOMIZED STUDY OF BEVACIZUMAB (BEV) PLUS STANDARD COMBINATION TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Saran, Frank
    Chinot, Olivier L.
    Henriksson, Roger
    Mason, Warren
    Wick, Wolfgang
    Nishikawa, Ryo
    Dahr, Sunita
    Hilton, Magalie
    Garcia, Josep
    Cloughesy, Timothy
    [J]. NEURO-ONCOLOGY, 2013, 15 : 127 - 128
12345